Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by sicilian2on Aug 17, 2017 6:16pm

107 Views

Post# 26594072

RE:RE:Wow

Word is getting out slowly. I hope he finds this new procedure as the next award winning find. I'm sure this will explode once the next patient results come out and continue to support its effectiveness to prostate cancer. In the meantime we should hear more on the human lung cancer treatment.

macman1519 wrote: Oh, and his award winning medal was for a feb 2016 story outlining cancer treatment based on the body's immune system

macman1519 wrote: An aquaintance of mine, Steve Buist, just won the Sanofi Pasteur Medal of Excellence in Health Research Journalism. He works for the Hamilton Spectator. Just emailed him a brief summary of Tlt. Will let you know how he responds. I really think Steve can be an important contact for us!!!! We will see.